Detalhe da pesquisa
1.
Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study).
Circulation
; 149(13): 993-1003, 2024 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38344820
2.
Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
Circulation
; 2024 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38583093
3.
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
N Engl J Med
; 387(12): 1089-1098, 2022 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36027570
4.
Empagliflozin in Heart Failure: Regional Nephron Sodium Handling Effects.
J Am Soc Nephrol
; 35(2): 189-201, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38073038
5.
Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial.
Circulation
; 148(22): 1735-1745, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37632455
6.
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
Circulation
; 148(24): 1945-1957, 2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37830208
7.
Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Circulation
; 147(14): 1067-1078, 2023 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36876483
8.
Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER.
Circulation
; 147(8): 624-634, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342789
9.
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
N Engl J Med
; 384(2): 129-139, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33200891
10.
Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin: A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER.
J Card Fail
; 30(3): 436-448, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38104937
11.
How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trial.
Nephrol Dial Transplant
; 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38323492
12.
Use of Sodium-Glucose Cotransporter Inhibitors in Type 1 Diabetes: The Promise and the Perils.
Endocr Pract
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548175
13.
Insulin Requirement and Infrainguinal Bypass Outcomes in Patients with Peripheral Arterial Disease.
Ann Vasc Surg
; 102: 25-34, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307234
14.
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
Eur Heart J
; 44(31): 2930-2943, 2023 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37220093
15.
Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trial.
Eur Heart J
; 44(40): 4233-4242, 2023 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37650264
16.
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.
Eur Heart J
; 44(24): 2170-2183, 2023 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37220172
17.
Ketones: the double-edged sword of SGLT2 inhibitors?
Diabetologia
; 66(1): 23-32, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36255460
18.
Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF.
Circulation
; 146(11): 808-818, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35603596
19.
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Circulation
; 146(16): 1210-1224, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36029465
20.
Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF.
Circulation
; 146(6): 438-449, 2022 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35442064